Annual EBITDA
$29.05B$4.04B+16.16%
Summary
- Current Value
- As of today, ABBV annual EBITDA is $29.05B, up +16.16% on
- Historical Performance
- ABBV annual EBITDA is down -6.49% over the past 3 years, up +31.45% over the past 5 years
- All-Time High Comparison
- ABBV annual EBITDA is currently -6.49% below its historical high of $31.07B set on
- 3-Year Low Comparison
- ABBV annual EBITDA is +16.16% above its 3-year low of $25.01B reached on
- Sector Comparison
- ABBV annual EBITDA is higher than 99.74% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $29.05B | +16.2% | -6.5% | +31.4% | +358.2% | |
| Quarterly EBITDA | $8.61B | +9.2% | +22.3% | +26.1% | +363.2% | |
| TTM EBITDA | $29.92B | +11.8% | -4.1% | +16.0% | +869.8% | |
| Price | $246.20 | +24.0% | +66.7% | +113.9% | – | |
| PE Ratio | 69.48 | -26.5% | +129.0% | +124.1% | – | |
| Annual Revenue | $61.16B | +8.6% | +5.3% | +33.5% | +291.1% | |
| Annual EPS | $2.36 | -1.2% | -64.4% | -13.3% | -10.7% | |
| Annual EBIT | $21.21B | +27.6% | -6.1% | +35.7% | +311.4% | |
| Annual Net Income | $4.19B | -1.3% | -64.4% | -8.1% | +0.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $31.07B | N/A | -6.5% |
| 5Y | $31.07B | -6.5% | |
| All | $31.07B | -6.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $25.01B | +16.2% | |
| 5Y | $22.10B | N/A | +31.4% |
| All | $5.84B | +397.4% |
EBITDA History
FAQ
- What is the current annual EBITDA of ABBV?
- As of today, ABBV annual EBITDA is $29.05B
- What is 1-year change in ABBV annual EBITDA?
- ABBV annual EBITDA is up +16.16% year-over-year
- What is 3-year change in ABBV annual EBITDA?
- ABBV annual EBITDA is down -6.49% over the past 3 years
- How far is ABBV annual EBITDA from its all-time high?
- ABBV annual EBITDA is currently -6.49% below its historical high of $31.07B set on December 31, 2022
- How does ABBV annual EBITDA rank versus sector peers?
- ABBV annual EBITDA is higher than 99.74% of companies in Healthcare sector
- When is ABBV next annual earnings release?
- As of today, the next annual earnings release for ABBV has not been scheduled
EBITDA Formula
Quarterly EBITDA
$8.61B$1.65B+23.70%
Summary
- Current Value
- As of today, ABBV quarterly EBITDA is $8.61B, up +23.70% on
- Historical Performance
- ABBV quarterly EBITDA is up +9.19% year-over-year, up +22.28% over the past 3 years
- All-Time High Comparison
- ABBV quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ABBV quarterly EBITDA is +70.08% above its 3-year low of $5.06B reached on
- Sector Comparison
- ABBV quarterly EBITDA is higher than 99.72% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $8.61B | +23.7% | +9.2% | +22.3% | +26.1% | |
| Annual EBITDA | $29.05B | – | +16.2% | -6.5% | +31.4% | |
| TTM EBITDA | $29.92B | +2.5% | +11.8% | -4.1% | +16.0% | |
| Price | $246.20 | +19.4% | +24.0% | +66.7% | +113.9% | |
| PE Ratio | 69.48 | -31.6% | -26.5% | +129.0% | +124.1% | |
| Quarterly Revenue | $16.99B | +13.3% | +10.2% | +22.5% | +21.7% | |
| Quarterly EPS | $2.04 | +428.4% | +289.3% | +79.5% | +383.8% | |
| Quarterly EBIT | $6.72B | +33.8% | +15.9% | +41.5% | +45.3% | |
| Quarterly Net Income | $3.62B | +427.2% | +289.0% | +79.7% | +381.6% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $8.61B | at high | |
| 3Y | $8.61B | at high | |
| 5Y | $8.61B | at high | |
| All | $8.61B | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.67B | +29.1% | |
| 3Y | $5.06B | +70.1% | |
| 5Y | $5.06B | +70.1% | |
| All | $381.85M | +2155.1% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of ABBV?
- As of today, ABBV quarterly EBITDA is $8.61B
- What is ABBV quarterly EBITDA most recent change?
- ABBV quarterly EBITDA was up +23.70% on June 30, 2026
- What is 1-year change in ABBV quarterly EBITDA?
- ABBV quarterly EBITDA is up +9.19% year-over-year
- How far is ABBV quarterly EBITDA from its all-time high?
- ABBV quarterly EBITDA is currently at its all-time high
- How does ABBV quarterly EBITDA rank versus sector peers?
- ABBV quarterly EBITDA is higher than 99.72% of companies in Healthcare sector
- When is ABBV next earnings release?
- The next earnings release for ABBV is on
EBITDA Formula
TTM EBITDA
$29.92B$725.00M+2.48%
Summary
- Current Value
- As of today, ABBV TTM EBITDA is $29.92B, up +2.48% on
- Historical Performance
- ABBV TTM EBITDA is up +11.84% year-over-year, down -4.10% over the past 3 years
- All-Time High Comparison
- ABBV TTM EBITDA is currently -5.83% below its historical high of $31.77B set on
- 3-Year Low Comparison
- ABBV TTM EBITDA is +19.82% above its 3-year low of $24.97B reached on
- Sector Comparison
- ABBV TTM EBITDA is higher than 99.81% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $29.92B | +2.5% | +11.8% | -4.1% | +16.0% | |
| Annual EBITDA | $29.05B | – | +16.2% | -6.5% | +31.4% | |
| Quarterly EBITDA | $8.61B | +23.7% | +9.2% | +22.3% | +26.1% | |
| Price | $246.20 | +19.4% | +24.0% | +66.7% | +113.9% | |
| PE Ratio | 69.48 | -31.6% | -26.5% | +129.0% | +124.1% | |
| TTM Revenue | $64.39B | +2.5% | +10.4% | +14.9% | +19.8% | |
| TTM EPS | $3.54 | +74.8% | +68.6% | -27.2% | -4.5% | |
| TTM EBIT | $22.02B | +4.4% | +19.4% | -1.9% | +29.2% | |
| TTM Net Income | $6.29B | +74.7% | +68.6% | -27.3% | -4.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $29.92B | at high | |
| 3Y | $31.20B | N/A | -4.1% |
| 5Y | $31.77B | -5.8% | |
| All | $31.77B | -5.8% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $26.75B | N/A | +11.8% |
| 3Y | $24.97B | +19.8% | |
| 5Y | $24.97B | +19.8% | |
| All | $1.23B | +2340.5% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of ABBV?
- As of today, ABBV TTM EBITDA is $29.92B
- What is ABBV TTM EBITDA most recent change?
- ABBV TTM EBITDA was up +2.48% on June 30, 2026
- What is 1-year change in ABBV TTM EBITDA?
- ABBV TTM EBITDA is up +11.84% year-over-year
- How far is ABBV TTM EBITDA from its all-time high?
- ABBV TTM EBITDA is currently -5.83% below its historical high of $31.77B set on March 31, 2023
- How does ABBV TTM EBITDA rank versus sector peers?
- ABBV TTM EBITDA is higher than 99.81% of companies in Healthcare sector
- When is ABBV next earnings release?
- The next earnings release for ABBV is on
EBITDA Formula
Data Sources & References
- ABBV Official Website www.abbvie.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm
- ABBV Profile on Yahoo Finance finance.yahoo.com/quote/ABBV
- ABBV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abbv
